Early Intervention for Psychosis by Katie Whyte

Perhaps too many years ago to admit; I had the fortune to become involved in the life of a young man who was diagnosed with schizophrenia.   I met him when he was first admitted, in his late teens; distressed, paranoid and suspicious and not exactly welcoming of inpatient treatment.  I tried to offer a sense of hope for recovery and provided him with the space to talk about his reservations about medication and his frustration with what he felt was restrictive and coercive mental health care.  Our relationship continued over the years when he experienced relapse and returned to the ward environment, usually detained under the mental health act, having stopped his anti-psychotic due to his perception that he was not unwell and his frustration about side effects of his medication.  Latterly, I felt hopeful when he appeared to gain some insight into his difficulties and was adhering to his medication.  But as a consequence, he was wrestling with the reality that whilst his siblings and peers were getting married, having children and settling into careers and new adventures, the reality for him was living on his own with an impoverished social network, unemployment, considerable weight gain with its resultant impact on his physical health, and a sense of hopelessness for the future.

It was with a heavy heart that a few months later, I found myself meeting his parents, for the first time, at his funeral.  I will never forget the compassion and gratitude that his parents expressed to me, and to the service, for supporting their son over the years.  As a parent myself, I often wonder why they were not angry and why they didn’t ask what we could have done better to prevent this tragic and untimely loss.  Because, the reality is, we, and I, could have done better.

In the first year of experiencing psychosis, a person is 12 times more at risk of taking their own life than the general population.  Suicide is the leading cause of premature death in individuals diagnosed with schizophrenia.  But a third of people who present with psychosis recover and never have another episode.  The trick, like most things in healthcare, is getting help early.  The challenge is doing this with people who either don’t think there’s anything wrong, don’t ask for help, or their living circumstances and lifestyles don’t exactly match our service model.

For the last year and half, I have had the pleasure of working with colleagues locally with support from third sector agencies, people with lived experience and Health Improvement Scotland to pilot an Early Intervention Psychosis service in our rural health board.  A first for Scotland, the naysayers challenge the need for this highly intensive, assertive approach to a relatively small group of service users when resources are increasingly rationalised and services overrun with demand.  Psychosis usually occurs for the first time in late adolescence or early 20s and if life goes off track for you then, the impact is arguably much more significant than if you have already met some of life’s important developmental milestones.  If we can get people treatment early and intensively, we can de-stigmatise psychosis and give hope for recovery and offer co-ordinated treatment including working alongside family and carers, vocational support and evidence based psychological therapies.  We can prevent hospital admissions, get people back to work or studies, improve relationships with their loved ones, reduce carer stress, and crucially, keep people alive.       

If you would like more information about Early Intervention Psychosis and our team, please get in touch and we’d be delighted to talk more about what we are doing, and what we hope to achieve in the future.

Katie Whyte is a Consultant Clinical Psychologist for NHS Dumfries and Galloway

Katie with Jamie Henderson (EIP Key Worker) & their Quality Improvement Trophy

The immeasurable importance of clinical trials -A guinea pig’s perspective and personal journey by Jamie Logan

Late October 2020, I woke with a feeling that a butterfly was using a battering ram to burst out of my chest. Shortness of breath, light headedness and chest tightness closely followed.
My first thought – “you’ve got me Covid, I’m ready for you – give me your best shot!”
Testing for “Corona” was routine back then, and to my great surprise, only one line was revealed.
What was happening to me?
I explained the symptoms to my GP and was immediately started on beta-blockers to slow my heart and anti-hypertensives to lower my blood pressure, then was referred to cardiology.
Fast forward 3 months and extensive tests (echos, MRI, Exercise testing), I was diagnosed with a heart condition- obstructive hypertrophic cardiomyopathy. Shock – this is hereditary. I was born with this – Mum had bowel cancer and is still going strong. Dad – not so lucky – Parkinson’s with Alzheimer’s and passed away 8 years ago. Neither were symptomatic, and I have since learned that my older sibling has recently been diagnosed with the same.
I was asked to look on British Heart Foundation website to familiarise myself with my condition, and in bold letters it stated : Possible Sudden Death ……….. this was getting scary!
I had always been active, a couple of marathons in the bag – so now I know why it took me 6 and a half hours to complete!
Absorbing this over a few further months, I was approached by a geneticist in Glasgow who took an extensive family history. As I had concerns I needed to talk about, she transferred my call to a Consultant Cardiologist, who invited me to a consultation in Glasgow.

This resulted in an informed invitation to trial a new unlicensed medication which would potentially treat my condition rather than the meds I was taking. These existing meds only helped control my symptoms, which admittedly had some undesirable side effects. I was screened in September 2022, passed the criteria required and was double blinded in the trial, unaware if I was on a placebo or the real deal.
Now, off the initial trial and awaiting results to determine if I was positive or negative for the medication, I have been given a further opportunity to participate in an extension for further research.  I actually know this time that I am on the Real McCoy now, and will remain on this until the time when enough statistics, hopefully favourable, will allow licensing. To be given the chance to participate is something so significant, to eventually help so many, leaves me feeling very humble.
I’ve been informed that there are less than 300 participants “world-wide”. The research team have been so supportive, as the emotion of coping with this has been overwhelming at times.

Don’t get me wrong, it’s not been all smooth running and there are factors that need to be considered – Long full days including travelling to research centre in Glasgow –( now made easier as I am taxied from home). Commitment for the long term study, and factoring in time off work to attend clinics. There was anxiety and reservations, from both myself and family, regarding untested medications – I was, in essence, a vulnerable candidate seeking a cure.

However, had I not been given this opportunity, I may well have resigned myself to the prospect of invasive surgery.

This has given me new hope.
Research is the essence to drive and develop new techniques, treatments as well as medications. Onwards and upwards, we learn as we go – development is essential for survival in a volatile environment, passing on the healthy outcomes ultimately to our service users.

Jamie Logan, Highly Specialist MSK Physiotherapist

Mountainhall Treatment Centre